Legal Opinion
ASTRAZENECA AB v. Impax Laboratories, Inc.
District Court, S.D. New York
Decided May 25, 2007No. 00 CIV. 7597(BSJ), 01 CIV. 2998(BSJ), M-21-81 (BSJ), MDL 1291PublishedCited by 4 opinions
1Opinion of the Court
Order
JONES, District Judge.
Presently before the Court is Impax Laboratories, Inc.’s Motion to Dismiss for Lack of Subject Matter Jurisdiction pursuant to Federal Rule of Civil Procedure 12(b)(1). For the reasons set forth below, Impax’s motion is DENIED.
Background
This is a patent infringement action brought by Plaintiffs AstraZeneca AB, Ak-tiebolaget Hassle, KBI-E Inc., KBI Inc., Astra Pharmaceuticals, L.P., and AstraZ-eneca, LP (collectively “Plaintiffs,” “As-traZeneca,” or “Astra”) against Impax Laboratories, Inc. (“Impax”), a manufacturer of generic pharmaceutical products in the United…
2Cases cited23 opinions
- Sibron v. New YorkSupreme Court of the United States · 1968
- Powell v. McCormackSupreme Court of the United States · 1969
- Natalia Makarova v. United StatesCourt of Appeals for the Second Circuit · 2000
- Honig v. DoeSupreme Court of the United States · 1988
- United States Parole Commission v. GeraghtySupreme Court of the United States · 1980
18 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Pfizer Inc. v. Apotex Inc.District Court, N.D. Illinois · 2010
- Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.District Court, E.D. Virginia · 2011
- The Iron Workers Local 580 Insurance Fund v. Novartis Pharmaceuticals CorporationDistrict Court, S.D. New York · 2026
- Vuppala v. Land of Buddha, Inc.District Court, S.D. New York · 2024